The offering, finalized on August 27, 2026, sets a combined effective price of $5.02 per share and accompanying warrants. Investors also have the option of pre-funded warrants priced at $5.019. These warrants carry an exercise price of $5.02 and are set to expire five years from the date of issuance, while pre-funded warrants feature an exercise price of $0.001 per share.
In section Releases
Tenon Medical Raises $3 Million in Private Placement
Tenon Medical, a developer of devices for sacro-pelvic disorders, has secured approximately $3 million through a private placement offering. Facilitated by WallachBeth Capital, the deal involves the sale of 597,610 shares of common stock and accompanying warrants, with the transaction expected to finalize by August 31, 2026.
WallachBeth Capital served as the sole placement agent for the transaction, which is being conducted under Section 4(a)(2) of the Securities Act of 1933 and Regulation D. Because these securities are not registered, Tenon Medical has committed to providing customary registration rights for the common stock and the shares underlying the various warrants. The company intends to close the deal pending the satisfaction of standard closing conditions.
Comments (0)
No comments yet. Be the first!